Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Moderna (MRNA) through the VizualStocks API.
Net product sales of Moderna's Spikevax and mNEXSPIKE COVID-19 vaccines to commercial customers, governments and international organizations. Sales are reported after estimated chargebacks, discounts, returns, government rebates and related deductions.
covidVaccineSalesModerna net product sales to customers in Europe, in U.S. dollars.
europeProductSalesModerna net product sales to customers in the rest of the world, in U.S. dollars.
restOfWorldProductSalesNet product sales of mRESVIA, Moderna's mRNA vaccine against respiratory syncytial virus, launched commercially in 2024. Sales are reported after estimated chargebacks, discounts, returns, government rebates and related deductions.
rsvVaccineSalesModerna net product sales to customers in the United States, in U.S. dollars.
unitedStatesProductSales